Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Genelux stock
Learn how to buy Genelux stock in 5 easy steps.
Genelux is a biotechnology business based in the US. Genelux shares (GNLX) are listed on the NASDAQ and all prices are listed in US Dollars. Genelux employs 15 staff and has a trailing 12-month revenue of around $11.1 million.
How to buy Genelux stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – GNLX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Commission-free stock and ETF trades
- No management fees
- Customizable portfolios with automatic rebalancing
Genelux stock price (NASDAQ: GNLX)Use our graph to track the performance of GNLX stocks over time.
Genelux shares at a glance
|Latest market close||$29.00|
|52-week range||$5.35 - $39.27|
|50-day moving average||$21.19|
|200-day moving average||$18.85|
|Wall St. target price||$10.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.23|
Buy Genelux stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Genelux stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Genelux price performance over time
Historical closes compared with the close of $29 from 2023-06-01
|1 week (2023-05-26)||20.83%|
|1 month (2023-05-03)||17.69%|
|3 months (2023-03-03)||57.01%|
|6 months (2022-11-29)||N/A|
|1 year (2022-05-30)||N/A|
|2 years (2021-05-30)||N/A|
|3 years (2020-05-30)||N/A|
|5 years (2018-05-30)||N/A|
|Revenue TTM||$11.1 million|
|Gross profit TTM||$11.1 million|
|Return on assets TTM||-27.58%|
|Return on equity TTM||0%|
|Market capitalisation||$704.7 million|
TTM: trailing 12 months
Genelux share dividends
We're not expecting Genelux to pay a dividend over the next 12 months.
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1, an animal health product candidate. It has a licensing agreement with ELIAS Animal Health, LLC. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California. .
Genelux in the news
Genelux Corporation Announces Publication of Positive Topline Data from Phase 2 VIRO-15 Trial Evaluating Olvimulogene Nanivacirepvec (Olvi-Vec) in Platinum-Resistant or Refractory Ovarian Cancer in the Journal of the American Medical Association (JAMA) Oncology
Genelux Corporation Announces $33 Million Private Placement
Frequently asked questionsWhat percentage of Genelux is owned by insiders or institutions?
Currently 17.73% of Genelux shares are held by insiders and 0.383% by institutions. How many people work for Genelux?
Latest data suggests 15 work at Genelux. When does the fiscal year end for Genelux?
Genelux's fiscal year ends in December.
More guides on Finder
JP Morgan Personal Advisors review 2023
Access remote advice, planning and portfolio management from this established financial services company.
How to buy Energy Transfer Equity stock
Steps to owning and managing ET, with 24-hour and historical pricing before you buy.
How to buy Uranium Energy stock
Steps to owning and managing UEC, with 24-hour and historical pricing before you buy.
How to buy Gold Royalty stock
Steps to owning and managing GROY, with 24-hour and historical pricing before you buy.
Best apps and platforms for ETF investing
The best trading apps come with low fees and are easy to use.
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
Best online brokers & platforms to buy gold stocks in June 2023
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
How to buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
Ask an Expert